Virobay Facts

2014 – Virobay to present data on two Cathepsin S inhibitor programs in neuropathic pain and Alzheimer's disease at the 2014 Society for Neuroscience Annual Meeting more

2014 – Virobay completes $8 million Series B preferred stock financing more

2014 – Virobay appoints Thomas J. Dietz, Ph.D. to the Virobay Board of Directors more


Contact Us

Virobay Inc.

Tel: +1 650-833-5700
Fax: +1 650-833-6892